Mark Rowland Hutchinson

Affiliations: 
Discipline of Physiology University of Adelaide, Adelaide, South Australia, Australia 
Area:
Neuroimmunopharmacology, Neuroscience, Immunology, Pharmacology
Google:
"Mark Hutchinson"
Mean distance: 18.41 (cluster 58)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chen KK, Hutchinson MR, Rolan P, et al. (2023) Effect of exercise on chronic neck pain and central sensitization: A protocol for a randomized crossover trial. Experimental Physiology
Mustafa S, Bajic JE, Barry B, et al. (2023) One immune system plays many parts: The dynamic role of the immune system in chronic pain and opioid pharmacology. Neuropharmacology. 109459
Madden VJ, Msolo N, Mqadi L, et al. (2022) Study protocol: an observational study of distress, immune function and persistent pain in HIV. Bmj Open. 12: e059723
Johnston CH, Whittaker AL, Franklin SH, et al. (2022) The Neuroimmune Interface and Chronic Pain Through the Lens of Production Animals. Frontiers in Neuroscience. 16: 887042
Mustafa S, Evans S, Barry B, et al. (2022) Toll-Like Receptor 4 in Pain: Bridging Molecules-to-Cells-to-Systems. Handbook of Experimental Pharmacology
Gilron I, Xiao MZX, Balanaser M, et al. (2022) Glial-modulating agents for the treatment of pain: protocol for a systematic review. Bmj Open. 12: e055713
Thomas JHL, Lui L, Abell A, et al. (2022) Toll-Like Receptors change morphine-induced antinociception, tolerance and dependence: studies using male and female TLR and Signalling gene KO mice. Brain, Behavior, and Immunity
Evans SF, Hull ML, Hutchinson MR, et al. (2021) Androgens, Endometriosis and Pain. Frontiers in Reproductive Health. 3: 792920
Moh ESX, Nishtala K, Iqbal S, et al. (2021) Long-term intrathecal administration of morphine vs. baclofen: Differences in CSF glycoconjugate profiles using multiglycomics. Glycobiology
Li H, Peng Y, Lin C, et al. (2021) Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling. Innovation (New York, N.Y.). 2: 100111
See more...